Table 1 Cytogenetic, immunophenotyping and methylation pattern of cells from patients used for the characterization of the ALL mice model

From: Preclinical activity of LBH589 alone or in combination with chemotherapy in a xenogeneic mouse model of human acute lymphoblastic leukemia

Sample

Karyotype

Immunophenotype

Percentage of blasts in patients' sample

Methylation pattern

ALL-T1

46, XX, del(1)(p32)?, del(6)(q23)?,t(11;14)(p13;q11)

CD3− CD7+ CD2+ CD5+ CD4+/− (60%)

CD3CITO+ CD34− CD10– CD1A− TDTlo+

>80%

325 Hypermethylated genes

49 Hypomethylated genes

ALL-B1

36,X,–Y,–2,–3,–4,–5,der(6q),–7,–9,–10,–14,–15,–16,–17,–18,–20,–22,+4 mar

CD45lo/verylo+ CD19+ CD34+(60%)

CD38hi+ CD22+ CD10– CD20−(12%)

TdT+(89%) CD3cito− CD7− CD2− CD5− CD1a− CD8− CD4− CD56− MPO− CD33− CD13− CD117− CD15lo+CD11b− CD11c− CD14− GlicoforineA– CD61− CD41a− CD42b− CD36−

98.40%

879 Hypermethylated genes

73 Hypomethylated genes

  1. Abbreviation: ALL, acute lymphoblastic leukemia.